Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $26 | $28 | $34 |
| - Cash | $2 | $12 | $15 | $18 |
| + Debt | $3 | $13 | $12 | $12 |
| Enterprise Value | $5 | $27 | $25 | $28 |
| Revenue | $3 | $19 | $22 | $16 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Gross Profit | $0 | $3 | $5 | $2 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| EBITDA | $0 | $1 | $2 | -$0 |
| % Margin | 6% | 5% | 10.4% | -1.9% |
| Net Income | $0 | $1 | $2 | -$0 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| Operating Cash Flow | $0 | $1 | -$4 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$4 | $4 |